Skip to main content

MYDA Advisors LLC

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 1589689 WOODMERE, NY

Position in ARQT

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$5,654,400
-$2,041,200 QoQ
Shares Held
240,000
-9.4% QoQ
Ownership
0.192%
of shares outstanding
% of Portfolio
1.63%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ARQT Over Time

Shares Held

Position Value (USD)

Derivatives in ARQT

reported options exposure · as of Sep 30, 2025
CallValue
$1,885,000
CallShares
100,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

MYDA Advisors LLC holds $37,336,697 across 11 Biotechnology names. ARQT ranks #3 (15.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 ARQT
Arcutis Biotherapeutics, Inc.
This page
240,000 $5,654,400

All Filings in ARQT

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $5,654,400 240,000
2025-12-31 $7,695,600 265,000
2025-09-30 $8,859,500 470,000
2025-09-30 $1,885,000 100,000
2025-06-30 $5,187,400 370,000
2025-03-31 $4,535,600 290,000
2024-12-31 $2,786,000 200,000
2024-09-30 $1,116,000 120,000
2024-09-30 $465,000 50,000
2024-06-30 $697,500 75,000
2024-03-31 $743,250 75,000
2023-12-31 $710,600 220,000